Statistics for Real-World Comparison of Major Bleeding Risk Among Untreated Non-Valvular Atrial Fibrillation Patients and Those Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin
Total visits
| views | |
|---|---|
| Real-World Comparison of Major Bleeding Risk Among Untreated Non-Valvular Atrial Fibrillation Patients and Those Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin | 33 |
Total visits per month
| views | |
|---|---|
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
Top country views
| views | |
|---|---|
| United States | 14 |
| China | 3 |
| United Kingdom | 2 |
| Japan | 2 |
| United Arab Emirates | 1 |
| Australia | 1 |
| Germany | 1 |
| Spain | 1 |
| South Korea | 1 |
| Lithuania | 1 |
| Netherlands | 1 |
| Thailand | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 1 |
| Birmingham | 1 |
| Chicago | 1 |
| Columbus | 1 |
| Gunsan | 1 |
| Kuiju | 1 |
| Rotterdam | 1 |
| Saitama | 1 |
| San Jose | 1 |
| Sarasota | 1 |
| Shanghai | 1 |
| Vilnius | 1 |